Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Vision-related quality of life in patients receiving intravitreal ranibizumab injections in routine clinical practice: baseline data from the German OCEAN study ; volume:14 ; number:1 ; day:20 ; month:9 ; year:2016 ; pages:1-11 ; date:12.2016
Health and quality of life outcomes ; 14, Heft 1 (20.9.2016), 1-11, 12.2016
- Urheber
-
Bertelmann, Thomas
- Beteiligte Personen und Organisationen
-
Feltgen, Nicolas
Scheffler, Martin
Hufenbach, Ulrich
Wiedon, Annette
Wilhelm, Helmut
Ziemssen, Focke
SpringerLink (Online service)
- DOI
-
10.1186/s12955-016-0536-1
- URN
-
urn:nbn:de:1111-201610219366
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Bertelmann, Thomas
- Feltgen, Nicolas
- Scheffler, Martin
- Hufenbach, Ulrich
- Wiedon, Annette
- Wilhelm, Helmut
- Ziemssen, Focke
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre study
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre study
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Risk analysis for patients with arterial thromboembolic events after intravitreal ranibizumab or aflibercept injections
Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial
Peripapillary choroidal thickness after intravitreal ranibizumab injections in eyes with neovascular age-related macular degeneration
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Iatrogenic Retinal Penetration from Intravitreal Injections
How to prevent endophthalmitis after intravitreal injections
Occlusive retinal vasculitis associated with intravitreal Faricimab injections
Benefit of intravitreal injections in patients with sub-threshold baseline visual acuity: a retrospective single-centre study
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study